New Scientist reports that researchers have tested an ALS gene therapy in a mouse model of disease.
In Genome Research this week: transcriptomic profiles of centenarians, role for PRDM9 expression in various tumor types, and more.
An American Cancer Society official has resigned due to concerns about partnerships with businesses with dubious health records, according to the New York Times.
Wired reports that increased diversity is needed in the Breakthrough Prizes.
National Geographic writes that some people may have a genetic predisposition to caffeine-induced jitters.
In PNAS this week: drug resistance evolution in Candida in a cystic fibrosis patient, point mutation in cotton bollworm allows it to persist in "Bt" crops, and more.
The Wellcome Trust and the Bill & Melinda Gates Foundation have joined the open-access initiative Plan S, according to ScienceInsider.
Australian insurers propose a cap for insurance policies below which customers don't have to disclose adverse genetic testing results, according to the Australian.
Indiana University School of Medicine's Aaron Carroll discusses the flaws and ways to improve peer review at the New York Times.
In PLOS this week: statistical approach for finding somatic mutation-based associations, genomic and methylomic patterns in virulent and non-virulent forms of a swine respiratory pathogen, and more.
Time reports that some experts have raised concerns about 23andMe's new direct-to-consumer pharmacogenetic tests.
ScienceInsider reports the National Science Foundation has stopped accepting applications for an initiative that enables fellows from its graduate fellowship program to study abroad.
In Science this week: computer model uses genomic data to investigate RNA virus outbreaks, and more.
Kaiser Health News reports on the high cost of targeted cancer therapies.
ETH Zurich has moved to dismiss a professor accused of bullying, according to ScienceInsider.
An Australian minister stopped the funding of 11 humanities projects selected through peer review, raising concerns among academics, Nature News reports.
Jennifer Raff writes at Forbes that some genomics scientists are engaging with under-represented communities for research.
In Nature this week: genomic and other analyses suggest the plant used to make chocolate was domesticated earlier and in a different region than previously thought, and more.
Researchers have uncovered two key genes for deer antler formation, the New York Times reports.
BGI was fined after found in 2015 to be conducting a genetics study illegally, according to the Global Times.
An investigation found no evidence of bullying or gender discrimination, but did find management flaws at the Wellcome Trust Sanger Institute, the Guardian reports.
In Genome Biology this week: comparative genomic study of endoderm differentiation, a single-cell sequencing method for small and messenger RNAs, and more.
Retraction Watch has launched its database of about 18,000 retracted papers.
Researchers are investigating whether swabbing newborns with their mothers' microbes will boost their own microbiome and prevent disease, according to NPR.
Othman Laraki, the CEO and co-founder of Color Genomics chats with Barron's Penta.
The National Science Foundation is adding questions about sexual orientation and gender identity to its Survey of Earned Doctorates, according to Science Careers.
Nature asked scientists whether they were satisfied with their careers to find that most were, with some variation.
Gene editing is expected to give rise to new job opportunities, according to BBC Capital.
A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.